Neuropace
NPCE
NPCE
80 hedge funds and large institutions have $268M invested in Neuropace in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
8% less call options, than puts
Call options by funds: $209K | Put options by funds: $226K
18% less funds holding
Funds holding: 98 → 80 (-18)
64% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 28
Holders
80
Holding in Top 10
1
Calls
$209K
Puts
$226K
Top Buyers
| 1 | +$31.9M | |
| 2 | +$6.65M | |
| 3 | +$1.5M | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.47M |
| 5 |
Goldman Sachs
New York
|
+$1.32M |
Top Sellers
| 1 | -$5.57M | |
| 2 | -$4.46M | |
| 3 | -$1.07M | |
| 4 |
Two Sigma Investments
New York
|
-$715K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$679K |
